Knowing the Score: Identifying Patients at High Risk of Liver Fibrosis from Non-Alcoholic Fatty Liver Disease (NAFLD)



About this Webinar

Date: Wednesday, March 11, 2015

Author: Bass, Nathan M., MD, PhD
Professor Emeritus of Medicine
Former Medical Director, UCSF Liver Transplantation Service
Division of Gastroenterology
UCSF Medical Center and School of Medicine  
Also by this Author 

Category: CE Credit, Webinar

Description: Nathan Bass, MD, discusses Non-Alcoholic Fatty Liver Disease (NAFLD) which is the most common cause of chronic liver disease in the United States. Dr. Bass defines what NAFLD is and why it is of growing concern in relationship to type 2 diabetes and explains the NAFLD Fibrosis Score and its importance.

At the conclusion of this program, participants will be able to:
• Define NAFLD and its role in the liver disease spectrum
• Understand the prevalence of NAFLD and why it is a growing concern in relation to type 2 diabetes mellitus
• State what the NAFLD Fibrosis Score is and what information it can provide
• Identify the benefits of knowing a patient's NAFLD Fibrosis Score
ASCLS P.A.C.E.® credits are available to laboratory professionals through June 8, 2015.